Evidence map›Paper›PMID 23509126›Full record

ArticleThe American journal of tropical medicine and hygiene2013

Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.

Jessica T Lin, Jaymin C Patel, Oksana Kharabora, Jetsumon Sattabongkot, Sinuon Muth, Ratawan Ubalee, Anthony L Schuster, William O Rogers, Chansuda Wongsrichanalai, Jonathan J Juliano

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2023
    Article
  9. Article
  10. Article
  11. Prevalence and temporal changes of mutations linked to antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Palawan, Philippines.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  12. Novel highly-multiplexed AmpliSeq targeted assay forFrontiers in cellular and infection microbiology · 2022
    Article
  13. Dynamic Classification ofJournal of data science : JDS · 2022
    Article
  14. High Proportion of Genome-Wide Homology and Increased PretreatmentAntimicrobial agents and chemotherapy · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jessica T LinDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA. Jessica_lin@med.unc.edu
Jaymin C Patel
Oksana Kharabora
Jetsumon Sattabongkot
Sinuon Muth
Ratawan Ubalee
Anthony L Schuster
William O Rogers
Chansuda Wongsrichanalai
Jonathan J Juliano
National Institute of Malaria Research · INOffice of Infectious Diseases · USUniversity of North Carolina at Chapel Hill · US

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
Within Host Selection of P. falciparum Variants by Artemisinin Combination TherapR01AI089819 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2010 to 2014
$1.9M
NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1RR025747NIAID NIH HHS 5T32AI0715132NIAID NIH HHS AI089819NIAID NIH HHS R01 AI089819
6 · The paper itself

Abstract

Plasmodium vivax accounts for an increasing fraction of malaria infections in Thailand and Cambodia. We compared P. vivax genetic complexity and antimalarial resistance patterns in the two countries. Use of a heteroduplex tracking assay targeting the merozoite surface protein 1 gene revealed that vivax infections in both countries are frequently polyclonal (84%), with parasites that are highly diverse (HE = 0.86) but closely related (GST = 0.18). Following a history of different drug policies in Thailand and Cambodia, distinct patterns of antimalarial resistance have emerged: most Cambodian isolates harbor the P. vivax multidrug resistance gene 1 (pvmdr1) 976F mutation associated with chloroquine resistance (89% versus 8%, P < 0.001), whereas Thai isolates more often display increased pvmdr1 copy number (39% versus 4%, P < 0.001). Finally, genotyping of paired isolates from individuals suspected of suffering relapse supports a complex scheme of relapse whereby recurrence of multiple identical variants is sometimes accompanied by the appearance of novel variants.

Indexed as

Polymorphism, Single NucleotideAllelesAntimalarialsATP-Binding Cassette, Sub-Family C ProteinsBiodiversityCambodiaChloroquineDrug ResistanceGene DosageGenotypeHeteroduplex AnalysisHumansMalaria, VivaxPlasmodium vivaxProtozoan ProteinsSequence Analysis, DNAAntimalarialsATP-Binding Cassette, Sub-Family C ProteinsChloroquineMdr1 protein, Plasmodium vivaxProtozoan Proteins

Identifiers

PMID23509126
PMCPMC3752811
OpenAlexW2167438163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.